Literature DB >> 20158611

Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-beta-dependent mechanisms.

Bryan L Copple1.   

Abstract

BACKGROUND/AIMS: During development of liver fibrosis, an important source of myofibroblasts is hepatocytes, which differentiate into myofibroblasts by epithelial to mesenchymal transition (EMT). In epithelial tumours and kidney fibrosis, hypoxia, through activation of hypoxia-inducible factors (HIFs), is an important stimulus of EMT. Our recent studies demonstrated that HIF-1alpha is important for the development of liver fibrosis. Accordingly, the hypothesis was tested that hypoxia stimulates hepatocyte EMT by a HIF-dependent mechanism.
METHODS: Primary mouse hepatocytes were exposed to room air or 1% oxygen and EMT evaluated. In addition, bile duct ligations (BDLs) were performed in control and HIF-1alpha-deficient mice and EMT quantified.
RESULTS: Exposure of hepatocytes to 1% oxygen increased expression of alpha-smooth muscle actin, vimentin, Snail and fibroblast-specific protein-1 (FSP-1). Levels of E-cadherin and zona occludens-1 were decreased. Upregulation of FSP-1 and Snail by hypoxia was completely prevented in HIF-1beta-deficient hepatocytes and by pretreatment with SB431542, a transforming growth factor-beta (TGF-beta) receptor inhibitor. HIFs promoted TGF-beta-dependent EMT by stimulating activation of latent TGF-beta1. To determine whether HIF-1alpha contributes to EMT in the liver during the development of fibrosis, control and HIF-1alpha-deficient mice were subjected to BDL. FSP-1 was increased to a greater extent in the livers of control mice when compared with HIF-1alpha-deficient mice.
CONCLUSIONS: Results from these studies demonstrate that hypoxia stimulates hepatocyte EMT by a HIF and TGF-beta-dependent mechanism. Furthermore, these studies suggest that HIF-1alpha is important for EMT in the liver during the development of fibrosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20158611      PMCID: PMC3111074          DOI: 10.1111/j.1478-3231.2010.02205.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  29 in total

1.  Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression.

Authors:  Stephanie McMahon; Martine Charbonneau; Sebastien Grandmont; Darren E Richard; Claire M Dubois
Journal:  J Biol Chem       Date:  2006-06-30       Impact factor: 5.157

2.  Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.

Authors:  Ghazaleh Tabatabai; Brigitte Frank; Robert Möhle; Michael Weller; Wolfgang Wick
Journal:  Brain       Date:  2006-07-10       Impact factor: 13.501

3.  Anticoagulation and inhibition of nitric oxide synthase influence hepatic hypoxia after monocrotaline exposure.

Authors:  Bryan L Copple; Robert A Roth; Patricia E Ganey
Journal:  Toxicology       Date:  2006-06-03       Impact factor: 4.221

4.  Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo.

Authors:  Erinn B Rankin; Mangatt P Biju; Qingdu Liu; Travis L Unger; Jennifer Rha; Randall S Johnson; M Celeste Simon; Brian Keith; Volker H Haase
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

5.  Early growth response factor-1 is critical for cholestatic liver injury.

Authors:  Nam Deuk Kim; Jeon-Ok Moon; Angela L Slitt; Bryan L Copple
Journal:  Toxicol Sci       Date:  2006-01-19       Impact factor: 4.849

6.  Hypoxia-inducible factor 1alpha regulates lung adenocarcinoma cell invasion.

Authors:  Kou-Gi Shyu; Feng-Lin Hsu; Ming Jen Wang; Bao-Wei Wang; Shankung Lin
Journal:  Exp Cell Res       Date:  2007-02-02       Impact factor: 3.905

7.  The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells.

Authors:  S M Wood; J M Gleadle; C W Pugh; O Hankinson; P J Ratcliffe
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

8.  Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1.

Authors:  B H Jiang; E Rue; G L Wang; R Roe; G L Semenza
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

9.  Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis.

Authors:  O Rosmorduc; D Wendum; C Corpechot; B Galy; N Sebbagh; J Raleigh; C Housset; R Poupon
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

10.  The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo.

Authors:  C Hellerbrand; B Stefanovic; F Giordano; E R Burchardt; D A Brenner
Journal:  J Hepatol       Date:  1999-01       Impact factor: 25.083

View more
  70 in total

1.  Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma.

Authors:  Shyamal Dilhan Weeraratne; Vladimir Amani; Natalia Teider; Jessica Pierre-Francois; Dominic Winter; Min Jeong Kye; Soma Sengupta; Tenley Archer; Marc Remke; Alfa H C Bai; Peter Warren; Stefan M Pfister; Judith A J Steen; Scott L Pomeroy; Yoon-Jae Cho
Journal:  Acta Neuropathol       Date:  2012-03-10       Impact factor: 17.088

Review 2.  Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease.

Authors:  Nels Olson; Albert van der Vliet
Journal:  Nitric Oxide       Date:  2011-01-01       Impact factor: 4.427

3.  Cross regulation between hypoxia-inducible transcription factor-1α (HIF-1α) and transforming growth factor (TGF)-ß1 mediates nickel oxide nanoparticles (NiONPs)-induced pulmonary fibrosis.

Authors:  Fenghua Qian; Mindi He; Weixia Duan; Lin Mao; Qian Li; Zhengping Yu; Zhou Zhou; Yong Zhang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

Review 4.  The roles of HLH transcription factors in epithelial mesenchymal transition and multiple molecular mechanisms.

Authors:  Yue Teng; Xu Li
Journal:  Clin Exp Metastasis       Date:  2013-10-26       Impact factor: 5.150

5.  Hepatocyte-derived Snail1 propagates liver fibrosis progression.

Authors:  R Grant Rowe; Yongshun Lin; Ryoko Shimizu-Hirota; Shinichiro Hanada; Eric G Neilson; Joel K Greenson; Stephen J Weiss
Journal:  Mol Cell Biol       Date:  2011-04-11       Impact factor: 4.272

6.  Spliced XBP1 Rescues Renal Interstitial Inflammation Due to Loss of Sec63 in Collecting Ducts.

Authors:  Yasunobu Ishikawa; Sorin Fedeles; Arnaud Marlier; Chao Zhang; Anna-Rachel Gallagher; Ann-Hwee Lee; Stefan Somlo
Journal:  J Am Soc Nephrol       Date:  2019-02-11       Impact factor: 10.121

7.  Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.

Authors:  Shaomei Cheng; Jingyan Guo; Qing Yang; Xiangshan Yang
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

8.  A high value of serum des-γ-carboxy prothrombin before hepatocellular carcinoma treatment can be associated with long-term liver dysfunction after treatment.

Authors:  Masaya Saito; Yasushi Seo; Yoshihiko Yano; Akira Miki; Masaru Yoshida; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2012-03-24       Impact factor: 7.527

9.  Hepatic stellate cells orchestrate clearance of necrotic cells in a hypoxia-inducible factor-1α-dependent manner by modulating macrophage phenotype in mice.

Authors:  Akie Mochizuki; Aaron Pace; Cheryl E Rockwell; Katherine J Roth; Aaron Chow; Kate M O'Brien; Ryan Albee; Kara Kelly; Keara Towery; James P Luyendyk; Bryan L Copple
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

10.  microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis.

Authors:  Timea Csak; Shashi Bala; Dora Lippai; Abishek Satishchandran; Donna Catalano; Karen Kodys; Gyongyi Szabo
Journal:  Liver Int       Date:  2014-07-28       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.